Humaid Al-Shamsi, Chief Executive Officer at Burjeel Cancer Institute and Regional Director of Burjeel Oncology GCC at Burjeel Holdings, also shared on LinkedIn:
“We were honored to host the Dana-Farber Cancer Institute team at Burjeel house / Burjeel Holdings during the WHX – World Health Expo Dubai last week.
Our discussions focused on the evolving landscape of cancer care in the UAE and the wider region, alongside global advances shaping the future of oncology. We explored strategic avenues for collaboration across research, education, and advanced clinical care, aligned with regional priorities and patient needs.
The sustained and active engagement of the DFCI team in the UAE underscores their commitment to supporting regional leadership in oncology and to building long-term partnerships that strengthen cancer care systems across the Middle East.”
Other articles featuring Humaid Al-Shamsi on OncoDaily.
